BRUSSELS, BELGIUM / EuroWire / — The Council of the European Union approved a framework to implement the EU Drugs Strategy and endorsed a new EU action plan against drug trafficking, setting out measures to address drug use, organized crime, public health risks and drug-related harm across the bloc. The decision, announced on June 4, places the 2026-2030 strategy into an operational phase and links health, justice, education and law enforcement work under a common EU structure.
The framework responds to what EU officials describe as growing health, security and societal challenges linked to drug use and trafficking. It is designed to coordinate political, policy and operational actors at local, national, EU and international levels, with a focus on reducing drug demand, limiting drug-related harm and countering trafficking networks. The endorsed action plan covers work to be carried out from 2026 to 2030.
The European Commission presented the new EU Drugs Strategy, the action plan against drug trafficking and updated rules on drug precursors in December 2025. The strategy builds on the 2021-2025 framework and covers preparedness, public health, security, harm reduction and international partnerships. It also reflects EU concerns over cocaine, synthetic drugs, precursor chemicals, online drug markets, maritime routes and the involvement of organized criminal groups in trafficking and distribution.
Framework targets trafficking networks
The action plan sets operational priorities for law enforcement, customs and judicial authorities, including stronger financial investigations and a follow-the-money approach. It also calls for reinforced maritime enforcement, wider use of the European Ports Alliance and expanded operations by the Maritime Analysis and Operations Centre Narcotics. Public-private cooperation is included, with attention to postal and parcel services, technology companies and risks linked to online recruitment, including the recruitment of minors.
The framework also covers prevention, treatment and reintegration measures based on evidence, while supporting voluntary cooperation between member states, EU agencies and other actors on demand reduction and harm reduction. The European Union Drugs Agency is expected to support monitoring, early warning and assessment work, including on new psychoactive substances and highly potent synthetic opioids. Europol is included in the wider law enforcement structure supporting member states against organized crime and trafficking.
Monitoring linked to 2032 report
The Council said implementation will use existing EU mechanisms, tools and processes, along with cooperation projects intended to strengthen work across borders. The plan includes measures addressing synthetic drugs and drug precursors, research and innovation, information exchange and international cooperation with non-EU countries and regions. It also places drug policy within a broader internal security agenda, while retaining public health measures as a central part of the bloc’s response.
EU leaders are due to discuss challenges linked to drug use and trafficking at the European Council meeting scheduled for June 18-19, marking the first time the topic is set for discussion at that level. Progress on the strategy will be monitored over time, and an overall implementation report is expected by the end of 2032. The report is intended to support evidence-based review of the EU drugs strategy and related action plan.